February 27, 2009 -- Advanced Life Sciences Holdings, Inc. , announced today that it has received notice from the U.S. FDA that the agency's Anti-Infective Drugs Advisory Committee (AIDAC) is tentatively scheduled to meet on June 2, 2009, and will discuss the New Drug Application for cethromycin, a new once-a-day oral antibiotic for the proposed indication of outpatient treatment of adults with mild-to-moderate community acquired pneumonia.
The details can be read here.
No comments:
Post a Comment